To test the effects of pharmacological inhibition of pyroptosis on AKI, we administered MCC950 (an inhibitor of NLRP3) or disulfiram (an inhibitor of GSDMD) (Hu et al., 2020) to C57BL/6 mice. Here, GSDMD is linked to acute kidney injury.